Cargando…
Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists
In cancer, immune checkpoint inhibitors (ICIs) improve patient survival but may lead to severe immune-related adverse events (irAEs). Rheumatic irAEs are a distinct entity that are much more common in a real-life than in clinical trial reports due to their unspecific symptoms and them being a rare c...
Autores principales: | Pacholczak-Madej, Renata, Kosałka-Węgiel, Joanna, Kuszmiersz, Piotr, Mituś, Jerzy W., Püsküllüoğlu, Mirosława, Grela-Wojewoda, Aleksandra, Korkosz, Mariusz, Bazan-Socha, Stanisława |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049070/ https://www.ncbi.nlm.nih.gov/pubmed/36981837 http://dx.doi.org/10.3390/ijerph20064926 |
Ejemplares similares
-
Endothelial dysfunction in patients with systemic sclerosis
por: Pacholczak-Madej, Renata, et al.
Publicado: (2020) -
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience
por: Pacholczak-Madej, Renata, et al.
Publicado: (2022) -
Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022) -
Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review
por: Püsküllüoğlu, Mirosława, et al.
Publicado: (2022) -
Prothrombotic state, endothelial injury, and echocardiographic changes in non-active sarcoidosis patients
por: Siwiec-Kozlik, Andzelika, et al.
Publicado: (2022)